112 related articles for article (PubMed ID: 29103327)
1. In vivo MR imaging of folate-receptor expression with the folate-specific nanospheres in a C6 glioblastoma model.
An Y; Tang Q; Yang R; Liu D; Zhang D
Comput Assist Surg (Abingdon); 2017 Dec; 22(sup1):312-318. PubMed ID: 29103327
[TBL] [Abstract][Full Text] [Related]
2. Folate/NIR 797-conjugated albumin magnetic nanospheres: synthesis, characterisation, and in vitro and in vivo targeting evaluation.
Tang Q; An Y; Liu D; Liu P; Zhang D
PLoS One; 2014; 9(9):e106483. PubMed ID: 25188308
[TBL] [Abstract][Full Text] [Related]
3. Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging.
Li H; Yan K; Shang Y; Shrestha L; Liao R; Liu F; Li P; Xu H; Xu Z; Chu PK
Acta Biomater; 2015 Mar; 15():117-26. PubMed ID: 25595473
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells.
Wang X; Tu M; Tian B; Yi Y; Wei Z; Wei F
Anal Biochem; 2016 Nov; 512():8-17. PubMed ID: 27523645
[TBL] [Abstract][Full Text] [Related]
6. In vivo magnetic resonance imaging tracking of C6 glioma cells labeled with superparamagnetic iron oxide nanoparticles.
Mamani JB; Malheiros JM; Cardoso EF; Tannús A; Silveira PH; Gamarra LF
Einstein (Sao Paulo); 2012; 10(2):164-70. PubMed ID: 23052451
[TBL] [Abstract][Full Text] [Related]
7. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
8. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
Meier R; Henning TD; Boddington S; Tavri S; Arora S; Piontek G; Rudelius M; Corot C; Daldrup-Link HE
Radiology; 2010 May; 255(2):527-35. PubMed ID: 20413763
[TBL] [Abstract][Full Text] [Related]
9. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
10. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy.
Ma X; Gong A; Chen B; Zheng J; Chen T; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2015 Feb; 126():44-9. PubMed ID: 25543982
[TBL] [Abstract][Full Text] [Related]
11. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
[TBL] [Abstract][Full Text] [Related]
12. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Shanavas A; Sasidharan S; Bahadur D; Srivastava R
J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma.
Shevtsov MA; Yakovleva LY; Nikolaev BP; Marchenko YY; Dobrodumov AV; Onokhin KV; Onokhina YS; Selkov SA; Mikhrina AL; Guzhova IV; Martynova MG; Bystrova OA; Ischenko AM; Margulis BA
Neuro Oncol; 2014 Jan; 16(1):38-49. PubMed ID: 24305705
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
15. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density.
Tang Z; Li D; Sun H; Guo X; Chen Y; Zhou S
Biomaterials; 2014 Sep; 35(27):8015-27. PubMed ID: 24947231
[TBL] [Abstract][Full Text] [Related]
16. Reduced toxicological manifestations of cisplatin following encapsulation in folate grafted albumin nanoparticles.
Alam N; Dubey RD; Kumar A; Koul M; Sharma N; Sharma PR; Chandan BK; Singh SK; Singh G; Gupta PN
Life Sci; 2015 Dec; 142():76-85. PubMed ID: 26482203
[TBL] [Abstract][Full Text] [Related]
17. Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.
Kim JH; Suh JY; Woo DC; Sung YS; Son WC; Choi YS; Pae SJ; Kim JK
NMR Biomed; 2016 Dec; 29(12):1688-1699. PubMed ID: 27723161
[TBL] [Abstract][Full Text] [Related]
18. Targeting chemo-proton therapy on C6 cell line using superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel.
Kang SH; Hong SP; Kang BS
Int J Radiat Biol; 2018 Nov; 94(11):1006-1016. PubMed ID: 30032692
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
20. The study on the preparation and characterization of gene-loaded immunomagnetic albumin nanospheres and their anti-cell proliferative effect combined with magnetic fluid hyperthermia on GLC-82 cells.
Zhang H; Hou X; Lin M; Wang L; Li H; Yuan C; Liang C; Zhang J; Zhang D
Drug Des Devel Ther; 2015; 9():6445-60. PubMed ID: 26719671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
